- Home
- ZDGE vs SYRS Comparison
ZDGE vs SYRS Comparison
Compare ZDGE & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- SYRS
- Stock Information
- Founded
- ZDGE 2008
- SYRS 2011
- Country
- ZDGE United States
- SYRS United States
- Employees
- ZDGE N/A
- SYRS N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- SYRS Health Care
- Exchange
- ZDGE Nasdaq
- SYRS Nasdaq
- Market Cap
- ZDGE 50.5M
- SYRS 52.5M
- IPO Year
- ZDGE N/A
- SYRS 2016
- Fundamental
- Price
- ZDGE $2.76
- SYRS $0.26
- Analyst Decision
- ZDGE
- SYRS Hold
- Analyst Count
- ZDGE 0
- SYRS 5
- Target Price
- ZDGE N/A
- SYRS $3.00
- AVG Volume (30 Days)
- ZDGE 61.1K
- SYRS 4.1M
- Earning Date
- ZDGE 12-11-2024
- SYRS 10-31-2024
- Dividend Yield
- ZDGE N/A
- SYRS N/A
- EPS Growth
- ZDGE N/A
- SYRS N/A
- EPS
- ZDGE N/A
- SYRS N/A
- Revenue
- ZDGE $30,091,000.00
- SYRS $386,000.00
- Revenue This Year
- ZDGE $16.71
- SYRS N/A
- Revenue Next Year
- ZDGE $16.10
- SYRS $1,011.11
- P/E Ratio
- ZDGE N/A
- SYRS N/A
- Revenue Growth
- ZDGE 10.46
- SYRS N/A
- 52 Week Low
- ZDGE $1.70
- SYRS $0.25
- 52 Week High
- ZDGE $5.18
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- ZDGE 40.05
- SYRS 27.55
- Support Level
- ZDGE $2.62
- SYRS $2.41
- Resistance Level
- ZDGE $2.99
- SYRS $3.40
- Average True Range (ATR)
- ZDGE 0.24
- SYRS 0.30
- MACD
- ZDGE 0.00
- SYRS -0.26
- Stochastic Oscillator
- ZDGE 26.14
- SYRS 0.33
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.